 Function GO Term   catalytic activity    And related genes <body> Function GO Term catalytic activity  and related genes   Total 1463 
Page number 12 * 	  Previous Page   *  Next Page    1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11   |   12   |   13   |   14   |   15   |   16   |   17   |   18   |   19   |   20   |   21   |   22   |   23   |   24   |   25   |   26   |   27   |   28   |   29   |   30   |   31   |   32   |   33   |   34   |   35   |   36   |   37   |   38   |   39   |   40   |   41   |   42   |   43   |   44   |   45   |   46   |   47   |   48   |   49  
    Gene Name  ORF Name   Function GO Term   Process GO Term  Component GO Term  Interacting Genes  Description  Gene Product  Phenotype     ERG12   YMR208W   mevalonate kinase activity   ergosterol biosynthesis  cytosol    mevalonate catabolism  mevalonate kinase  Null mutant is inviable and unable to grow vegetatively or germinate spores; mutants exhibit increas     ERG13   YML126C   hydroxymethylglutaryl-CoA synthase activity   ergosterol biosynthesis  mitochondrion*  YNL119W	YFL039C	YIL094C	YLR180W	YKL125W	YDL188C	YJR091C	YMR059W	  involved in mevalonate synthesis  3-hydroxy-3-methylglutaryl coenzyme A synthase       ERG2   YMR202W   C-8 sterol isomerase activity   ergosterol biosynthesis  endoplasmic reticulum  YGL127C	YJR091C	YCR034W	YNL271C	  sterol biosynthesis  C-8 sterol isomerase  synthetic lethal with vma2.     ERG20   YJL167W   dimethylallyltranstransferase activity*   ergosterol biosynthesis*  cytosol  YDL186W	YNL244C	YJR035W	YBR055C	YPL149W	YDR369C	  May be rate-limiting step in sterol biosynthesis pathway  farnesyl diphosphate synthetase (FPP synthetase)  Null mutant is inviable     ERG24   YNL280C   C-14 sterol reductase activity   ergosterol biosynthesis  endoplasmic reticulum  YDL153C	YHR114W	  sterol C-14 reductase  sterol C-14 reductase  Null mutant appears to be inviable in some genetic backgrounds and conditionally lethal in others; e     ERG25   YGR060W   C-4 methyl sterol oxidase activity   ergosterol biosynthesis  plasma membrane*  YJL202C	YGL001C	YDR113C	  membrane-bound non-heme di-iron oxygenase involved in lipid metabolism.  C-4 sterol methyl oxidase  Null mutant is inviable     ERG26   YGL001C   C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity   ergosterol biosynthesis  endoplasmic reticulum*  YGR060W	YBR202W	  one of three enzymatic activities required for the conversion of 4,4-dimethylzymosterol to zymostero  C-3 sterol dehydrogenase       ERG27   YLR100W   3-keto sterol reductase activity   ergosterol biosynthesis  endoplasmic reticulum*  YGL137W	YDL132W	YBL005W	  3-keto sterol reductase  3-keto sterol reductase       ERG3   YLR056W   C-5 sterol desaturase activity   ergosterol biosynthesis  endoplasmic reticulum  YHR128W	YIL074C	YOL099C	YOR167C	YNL271C	  C-5 sterol desaturase  C-5 sterol desaturase  Null mutant is inviable; suppresses syringomycin resistant mutant; sensitive to photoactivated 3-car     ERG4   YGL012W   delta24(24-1) sterol reductase activity   ergosterol biosynthesis  endoplasmic reticulum    Sterol C-24 reductase  sterol C-24 reductase  Null mutant is viable     ERG5   YMR015C   C-22 sterol desaturase activity   ergosterol biosynthesis  endoplasmic reticulum    cytochrome P450 involved in C-22 denaturation of the ergosterol side-chain  cytochrome P450|involved in C-22 denaturation of the ergosterol side-chain  Null mutant is viable     ERG6   YML008C   sterol 24-C-methyltransferase activity   ergosterol biosynthesis  endoplasmic reticulum*  YCL023C	YDL089W	YHR114W	YOR097C	YPL020C	YPR113W	YMR059W	  ergosterol synthesis    The null mutant is viable, cannot methylate ergosterol precursors at C-24, and lacks ergosterol. The     ERG7   YHR072W   lanosterol synthase activity   ergosterol biosynthesis  plasma membrane*    carries out complex cyclization step of squalene to lanosterol in sterol biosynthesis pathway  2,3-oxidosqualene-lanosterol cyclase  Null mutant is inviable     ERG8   YMR220W   phosphomevalonate kinase activity   ergosterol biosynthesis*  cytosol    Involved in isoprene and ergosterol biosynthesis pathways  48 kDa phosphomevalonate kinase  Null mutant is inviable     ERG9   YHR190W   farnesyl-diphosphate farnesyltransferase activity   ergosterol biosynthesis  endoplasmic reticulum  YIR038C	YMR153W	YLR453C	  squalene synthetase  squalene synthetase  Null mutant is inviable     ERR1   YOR393W   phosphopyruvate hydratase activity   biological_process unknown  cellular_component unknown  YOR128C	  enolase-related subtelomeric sequence (ERR1 and ERR2 code for identical proteins)  enolase homolog       ERR2   YPL281C   phosphopyruvate hydratase activity   biological_process unknown  cellular_component unknown    enolase-related subtelomeric sequence (ERR1 and ERR2 code for identical proteins)         ERV1   YGR029W   thiol oxidase activity   iron ion homeostasis*  mitochondrion*    Protein forms dimers in vivo and in vitro, contains a conserved YPCXXC motif at carboxyl-terminal, b  sulfhydryl oxidase  Null mutant is inviable; mutants demonstrate defects in mitochondrial biogenesis     ERV2   YPR037C   thiol oxidase activity   protein thiol-disulfide exchange  microsome  YDL100C	YPR156C	  Essential for Respiration and Vegetative growth 2. Protein forms dimers in vivo/vitro, contains a co    Deletion of ERV2 or depletion of Erv2p by regulated gene expression is not associated with any detec     ESA1   YOR244W   histone acetyltransferase activity   regulation of transcription from Pol II promoter*  histone acetyltransferase complex  YKR021W	YFL039C	YHR099W	YOL086C	YML007W	YDR359C	YPR023C	YNL107W	YJL081C	YFL024C	YDR271C	YJL098W	  contains amino-terminal chromodomains; Essential SAS family Acetyltransferase sharing homology with  NuA4 complex component|acetyltransferase in the SAS gene family  Null mutant is inviable     ESP1   YGR098C   cysteine-type endopeptidase activity   regulation of exit from mitosis*  nucleus*  YDR113C	YGR163W	  Esp1 promotes sister chromatid separation by mediating dissociation from the chromatin of the cohesi  separase  Null mutant is inviable, produces extra spindle pole bodies, shows disrupted cell cycle control     ESS1   YJR017C   peptidyl-prolyl cis-trans isomerase activity   mRNA processing*  nucleus  YHR033W	YML010W	YHR027C	YGR090W	YLR216C	YLR438W	YGR253C	YLR106C	YNL014W	YIL033C	YGR186W	YIL021W	YLL026W	YDR343C	YDL140C	YDR457W	YPR086W	  Mitotic regulator; structurally and functionally homologous to human PIN1  peptidyl-prolyl cis-trans isomerase (PPIase)  Null mutant is inviable; arrest phenotype of mitotic arrest and nuclear fragmentation     EST2   YLR318W   telomeric template RNA reverse transcriptase activity   telomerase-dependent telomere maintenance  nucleus*  YLR039C	YLR262C	YLR085C	  Contributes to the catalytic activity of telomerase and to other aspects of telomerase assembly and  telomerase reverse transcriptase  Null mutant is viable, exhibits progressively shorter telomeres, cellular senescence and a telomeras     EST3   YIL009C-A   telomerase activity   telomerase-dependent telomere maintenance  nucleus*  YML092C	  ever shorter telomeres  20.5 kDa 181aa protein  Null mutant shows progressively shorter telomeres and cellular senescence; telomerase activity is st     ETR1   YBR026C   enoyl-acyl-carrier protein reductase activity   aerobic respiration*  mitochondrion    Involved in mitochondrial fatty acid biosynthesis  2-enoyl thioester reductase, E.C. 1.3.1.-  Null mutant is viable but is respiratory-deficient     EUG1   YDR518W   protein disulfide isomerase activity   protein folding  endoplasmic reticulum  YCL043C	  ER protein functionally likely involved in interacting with nascent polypeptides in the ER  protein disulfide isomerase homolog  Null mutant is viable     EXG1   YLR300W   glucan 1,3-beta-glucosidase activity   cell wall organization and biogenesis*  cell wall (sensu Fungi)  YMR049C	YOL126C	  Has a broad specificity for beta-1,3-linkages as well as beta-1,6-linkages, and also for other beta-  exo-1,3-beta-glucanase  Null mutant is viable, displays modest increase in killer toxin sensitivity and beta 1,6-glucan leve     EXG2   YDR261C   glucan 1,3-beta-glucosidase activity   biological_process unknown  cell wall (sensu Fungi)    Exo-1,3-b-glucanase  exo-1,3-beta-glucanase  Null mutant is viable     EXO1   YOR033C   exonuclease activity*   mismatch repair  nucleus  YOL090W	YJR091C	YKL113C	YOL006C	  Protein that complements a drug-hypersensitive mutation. EXO1 plays a structural role in MMR and sta  exonuclease  Mutants demonstrate sensitivity to cycloheximide, bleomycin, actinomycin D, 5-fluorouracil, and seve     FAA1   YOR317W   long-chain-fatty-acid-CoA ligase activity   lipid metabolism*  lipid particle  YBR064W	YBR239C	YJR091C	YLR373C	YBR017C	YDL047W	YCR079W	YGR092W	YKR026C	  cellular lipid metabolism and protein N-myristolation  long chain fatty acyl:CoA synthetase  Null mutant is viable as long as fatty acid synthase (fas) complex is active   </body> 